Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine

Ventricular assist devices (VADs) are used to provide mechanical circulatory support to patients with end-stage heart failure. The driveline connecting the external power source to the pump(s) of the intra-corporal VAD breaches the protective skin barrier and provides a track for microbes to invade...

Full description

Bibliographic Details
Main Authors: Johannes Weichsel, Benito Baldauf, Hendrik Bonnemeier, Ernest W. Lau, Sven Dittrich, Robert Cesnjevar
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/9/1/18
_version_ 1827664879933194240
author Johannes Weichsel
Benito Baldauf
Hendrik Bonnemeier
Ernest W. Lau
Sven Dittrich
Robert Cesnjevar
author_facet Johannes Weichsel
Benito Baldauf
Hendrik Bonnemeier
Ernest W. Lau
Sven Dittrich
Robert Cesnjevar
author_sort Johannes Weichsel
collection DOAJ
description Ventricular assist devices (VADs) are used to provide mechanical circulatory support to patients with end-stage heart failure. The driveline connecting the external power source to the pump(s) of the intra-corporal VAD breaches the protective skin barrier and provides a track for microbes to invade the interior of the patient’s body. Driveline infection constitutes a major and potentially fatal vulnerability of VAD therapy. Driveline infection cannot traditionally be salvaged and requires the extraction of the entire VAD system. We report here the successful eradication of a VAD driveline infection with a taurolidine-containing antimicrobial solution used for preventing the infection of cardiac implantable electronic devices. If replicated in more cases, the novel treatment concept described here may provide a valuable alternative management strategy of salvage rather than explantation for VAD driveline infection.
first_indexed 2024-03-10T01:14:49Z
format Article
id doaj.art-111ce62dd1344900acf02d21d2c0d086
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-10T01:14:49Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-111ce62dd1344900acf02d21d2c0d0862023-11-23T14:11:10ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252022-01-01911810.3390/jcdd9010018Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with TaurolidineJohannes Weichsel0Benito Baldauf1Hendrik Bonnemeier2Ernest W. Lau3Sven Dittrich4Robert Cesnjevar5Department of Paediatric Cardiology, University Hospital Erlangen, 91054 Erlangen, GermanyMedical Faculty, Christian-Albrechts University Kiel, 24118 Kiel, GermanyMedical Faculty, Christian-Albrechts University Kiel, 24118 Kiel, GermanyDepartment of Cardiology, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, UKDepartment of Paediatric Cardiology, University Hospital Erlangen, 91054 Erlangen, GermanyDepartment of Paediatric Cardiothoracic Surgery, University Hospital Erlangen, 91054 Erlangen, GermanyVentricular assist devices (VADs) are used to provide mechanical circulatory support to patients with end-stage heart failure. The driveline connecting the external power source to the pump(s) of the intra-corporal VAD breaches the protective skin barrier and provides a track for microbes to invade the interior of the patient’s body. Driveline infection constitutes a major and potentially fatal vulnerability of VAD therapy. Driveline infection cannot traditionally be salvaged and requires the extraction of the entire VAD system. We report here the successful eradication of a VAD driveline infection with a taurolidine-containing antimicrobial solution used for preventing the infection of cardiac implantable electronic devices. If replicated in more cases, the novel treatment concept described here may provide a valuable alternative management strategy of salvage rather than explantation for VAD driveline infection.https://www.mdpi.com/2308-3425/9/1/18left ventricular assist deviceinfectiondrivelinetaurolidine
spellingShingle Johannes Weichsel
Benito Baldauf
Hendrik Bonnemeier
Ernest W. Lau
Sven Dittrich
Robert Cesnjevar
Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine
Journal of Cardiovascular Development and Disease
left ventricular assist device
infection
driveline
taurolidine
title Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine
title_full Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine
title_fullStr Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine
title_full_unstemmed Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine
title_short Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine
title_sort eradication of ventricular assist device driveline infection in paediatric patients with taurolidine
topic left ventricular assist device
infection
driveline
taurolidine
url https://www.mdpi.com/2308-3425/9/1/18
work_keys_str_mv AT johannesweichsel eradicationofventricularassistdevicedrivelineinfectioninpaediatricpatientswithtaurolidine
AT benitobaldauf eradicationofventricularassistdevicedrivelineinfectioninpaediatricpatientswithtaurolidine
AT hendrikbonnemeier eradicationofventricularassistdevicedrivelineinfectioninpaediatricpatientswithtaurolidine
AT ernestwlau eradicationofventricularassistdevicedrivelineinfectioninpaediatricpatientswithtaurolidine
AT svendittrich eradicationofventricularassistdevicedrivelineinfectioninpaediatricpatientswithtaurolidine
AT robertcesnjevar eradicationofventricularassistdevicedrivelineinfectioninpaediatricpatientswithtaurolidine